Literature DB >> 33223511

Construction of circRNA-based ceRNA network to reveal the role of circRNAs in the progression and prognosis of metastatic clear cell renal cell carcinoma.

Xiyi Wei1, Yuxiang Dong1,2, Xinglin Chen1, Xiaohan Ren1, Guangyao Li1, Yamin Wang1, Yichun Wang1, Tongtong Zhang1, Shangqian Wang1, Chao Qin1, Ninghong Song1,3.   

Abstract

CircRNAs are now under hot discussion as novel promising bio-markers for patients with clear cell renal cell carcinoma. The purpose of our study is to identify several circRNAs related to the metastasis and progression of clear cell renal cell carcinoma, and to further investigate the mechanism of their influence on tumor progression. The transcriptome data of ccRCC and clinical characteristics used in this study were downloaded from the The Cancer Genome Atlas and Gene Expression Omnibus database. A total of 114 circRNAs were found to be related to tumor initiation, progression and metastasis after the intersection. In addition, 14 miRNAs and 201 eligible mRNAs were selected as targets gene, respectively. CeRNA network was constructed based on 8 circRNAs, 14 miRNAs, and 201 mRNAs. Besides, another 6 hub genes were identified via the PPI network. It should be noted that only TRIM2 was confirmed as an independent prognostic factor, which was simultaneously significantly related to both clinical stage and pathological grade in clinical cohorts. Kyoto Encyclopedia of Genes and Genomes and Gene Ontology analysis indicated the possible function of TRIM2 in ccRCC progression, such as ubiquitin mediated protein hydrolysis, cell adhesion molecules, Th17 cell differentiation signaling pathway and so on. Gene set enrichment analysis analysis revealed that TRIM2 may be involved in ubiquitin mediated proteolysis, apoptosis, autophagy and citrate cycle TCA cycle. Hub circ_RNAs expressions were validated in ccRCC tissues and cell lines. Our study revealed that the hsa_circ_0002286 / has-mir-222-5p / TRIM2 axis played a critical role in the progression of ccRCC. Specifically, it may inhibit the metastasis and progression of ccRCC, which could serve as a potential therapeutic target.

Entities:  

Keywords:  CircRNAs; ceRNA; clear cell renal cell carcinoma; hsa_circ_0002286; metastasis

Mesh:

Substances:

Year:  2020        PMID: 33223511      PMCID: PMC7762515          DOI: 10.18632/aging.104107

Source DB:  PubMed          Journal:  Aging (Albany NY)        ISSN: 1945-4589            Impact factor:   5.682


  44 in total

Review 1.  The dichotomous nature of T helper 17 cells.

Authors:  Brigitta Stockinger; Sara Omenetti
Journal:  Nat Rev Immunol       Date:  2017-05-30       Impact factor: 53.106

Review 2.  A Systematic Review and Meta-analysis Comparing the Effectiveness and Adverse Effects of Different Systemic Treatments for Non-clear Cell Renal Cell Carcinoma.

Authors:  Sergio Fernández-Pello; Fabian Hofmann; Rana Tahbaz; Lorenzo Marconi; Thomas B Lam; Laurence Albiges; Karim Bensalah; Steven E Canfield; Saeed Dabestani; Rachel H Giles; Milan Hora; Markus A Kuczyk; Axel S Merseburger; Thomas Powles; Michael Staehler; Alessandro Volpe; Börje Ljungberg; Axel Bex
Journal:  Eur Urol       Date:  2016-12-08       Impact factor: 20.096

3.  SIRT1 Regulates N6 -Methyladenosine RNA Modification in Hepatocarcinogenesis by Inducing RANBP2-Dependent FTO SUMOylation.

Authors:  Xiaoming Liu; Jianye Liu; Wen Xiao; Qinghai Zeng; Hao Bo; Yuxing Zhu; Lian Gong; Dong He; Xiaowei Xing; Ruhong Li; Ming Zhou; Wei Xiong; Yanhong Zhou; Jianda Zhou; Xiaohui Li; Fei Guo; Canxia Xu; Xiong Chen; Xiaoyan Wang; Fen Wang; Qiang Wang; Ke Cao
Journal:  Hepatology       Date:  2020-10-22       Impact factor: 17.425

4.  A gene signature to predict high tumor-infiltrating lymphocytes after neoadjuvant chemotherapy and outcome in patients with triple-negative breast cancer.

Authors:  C Criscitiello; M A Bayar; G Curigliano; F W Symmans; C Desmedt; H Bonnefoi; B Sinn; G Pruneri; C Vicier; J Y Pierga; C Denkert; S Loibl; C Sotiriou; S Michiels; F André
Journal:  Ann Oncol       Date:  2018-01-01       Impact factor: 32.976

Review 5.  Treatment of renal cell carcinoma: Current status and future directions.

Authors:  Pedro C Barata; Brian I Rini
Journal:  CA Cancer J Clin       Date:  2017-09-29       Impact factor: 508.702

6.  TRIM37 is a new histone H2A ubiquitin ligase and breast cancer oncoprotein.

Authors:  Sanchita Bhatnagar; Claude Gazin; Lynn Chamberlain; Jianhong Ou; Xiaochun Zhu; Jogender S Tushir; Ching-Man Virbasius; Ling Lin; Lihua J Zhu; Narendra Wajapeyee; Michael R Green
Journal:  Nature       Date:  2014-11-24       Impact factor: 49.962

7.  Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs.

Authors:  Qiupeng Zheng; Chunyang Bao; Weijie Guo; Shuyi Li; Jie Chen; Bing Chen; Yanting Luo; Dongbin Lyu; Yan Li; Guohai Shi; Linhui Liang; Jianren Gu; Xianghuo He; Shenglin Huang
Journal:  Nat Commun       Date:  2016-04-06       Impact factor: 14.919

8.  Circ-ZNF609 Is a Circular RNA that Can Be Translated and Functions in Myogenesis.

Authors:  Ivano Legnini; Gaia Di Timoteo; Francesca Rossi; Mariangela Morlando; Francesca Briganti; Olga Sthandier; Alessandro Fatica; Tiziana Santini; Adrian Andronache; Mark Wade; Pietro Laneve; Nikolaus Rajewsky; Irene Bozzoni
Journal:  Mol Cell       Date:  2017-03-23       Impact factor: 17.970

Review 9.  Every step of the way: integrins in cancer progression and metastasis.

Authors:  Hellyeh Hamidi; Johanna Ivaska
Journal:  Nat Rev Cancer       Date:  2018-09       Impact factor: 60.716

10.  A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs.

Authors:  Chuan Huang; Dongming Liang; Deirdre C Tatomer; Jeremy E Wilusz
Journal:  Genes Dev       Date:  2018-05-17       Impact factor: 11.361

View more
  5 in total

Review 1.  The functions, oncogenic roles, and clinical significance of circular RNAs in renal cell carcinoma.

Authors:  Hui Huang; Tao Chen; Fei Li; Dan Jin; Chuan Li; Yongbo Yang; Xuyang Liu; Dongmiao Wang; Jiehui Di
Journal:  Med Oncol       Date:  2022-05-15       Impact factor: 3.064

Review 2.  CircRNAs as Novel Biomarkers and Therapeutic Targets in Renal Cell Carcinoma.

Authors:  Yuxia Zhou; Cheng Li; Zhenping Wang; Shuangfeng Tan; Yiqi Liu; Hu Zhang; Xuefeng Li
Journal:  Front Mol Biosci       Date:  2022-02-11

Review 3.  Expression and Role of TRIM2 in Human Diseases.

Authors:  Maolin Xiao; Jianjun Li; Qingyuan Liu; Xiangbiao He; Zongke Yang; Delin Wang
Journal:  Biomed Res Int       Date:  2022-08-23       Impact factor: 3.246

4.  Characterizing the molecular heterogeneity of clear cell renal cell carcinoma subgroups classified by miRNA expression profile.

Authors:  Tao Shen; Yingdong Song; Xiangting Wang; Haiyang Wang
Journal:  Front Mol Biosci       Date:  2022-08-26

5.  Construction of circRNA-based ceRNA network and its prognosis-associated subnet of clear cell renal cell carcinoma.

Authors:  Yuwei Zhang; Yuchen Zhang; Yangkun Feng; Nan Zhang; Saisai Chen; Chaoqun Gu; Lei Hu; Jiayi Sheng; Bin Xu; Ninghan Feng
Journal:  Cancer Med       Date:  2021-09-27       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.